Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...

Eli Lilly plans to launch its diabetes and weight-loss drug, Mounjaro, in emerging markets such as India, Brazil, and Mexico in 2025. The expansion leverages growing demand in populous countries ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

Micheál Martin may need to pledge some material incentives to increase the size of Irish business investors in the US ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

Eli Lilly has said it is seeking permission to build ... €400 million ($445 million), and could create 300 jobs at the plant itself, with another 500 positions required while it is under ...

The commerce secretary said any economic downturn would be because of Biden-era policies, arguing that Trump’s tariffs are spurring economic growth in the U.S.

Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S ...